A study on evaluation of antidepressant effect of Imipramine adjunct with Ashwagandha and Bramhi
Introduction: Depressive disorders increases the risks of self-harm or even suicide in patients. Indigenous drugs are being tried to treat such patient along with conventional antidepressant drugs. Objective: To investigate the antidepressant action of Ashwagandha and Bramhi and also to confirm its efficacy in the behavioural despair animal model of depression. Material and methods: Normal saline as control (5ml/kg), imipramine as standard (16,32,64 mg/kg) and ashwagandha (50,100,150 mg/kg), bramhi (20,40,80 mg/kg) as test drugs were introduced to the albino rats weighing between 200-250gm for 2 weeks, 1 hr before electric shock in Learned helplessness test (LHT) and swimming in Forced swimming test (FST). Effects of individual drugs as well as their combination were evaluated. Result: Avoidance response, escape failure and immobility period in case of imipramine and ashwagandha showed highly significant (p<0.01) result on individual use. There was no significant result in case of Bramhi used alone except in escape failure and immobility period (FST), where at higher doses it showed significant (p<0.01) result . But combination of Bramhi and ashwagandha in low doses with low dose of imipramine gave a highly significant result (p<0.01) in all the parameters. Conclusion: Ashwagandha had significant antidepressant action, but bramhi had not when used alone. Combination of these two indigenous drugs with imipramine showed high efficacy in animal model.
The author hereby transfers, assigns, orÂ conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of theÂ IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.